Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Monday, June 22, 2026

Snapshot: Jun 22, 2026 · 6:00 PM 100 stocks analyzed

Up Day

Mon, Jun 22, 2026 Small-Cap Rally High

Russell 2000 surged 2.05% as small caps massively outpaced the S&P 500's 0.56% gain, with extreme dispersion and healthcare sector dominance propelling a high-conviction rotatio…

60% Small-cap rally overwhelmed broad-market gains as Russell 2000 jumped 2.05% versus S&P 500's 0.56%, a 1.5-percentage-point lead that signals decisive money rotation into micro and mid-cap names. High dispersion (50+ stocks moving >25%) reinforced the stock-pickers character, with extreme winners like NXTS (+156%, AI drug partnership), GETY (+90%, OpenAI licensing), and SKYQ (+62%, refinery production milestone) anchoring the upside.
25% Healthcare sector dominated the gainers list at 36% of top-50 risers, driven by clinical wins and regulatory tailwinds—DFTX surged 50% on Phase 3 depression-treatment success, ENTX +22% on FDA backing for osteoporosis trial, RGNX +16% on gene-therapy reconsideration, and NVCET +19.6% on a pipeline expansion licensing deal. The concentration underscores therapeutic optimism outweighing sector-wide caution.
15% Four-day gainer streaks in CAST and HQ, plus five debutant names (APGE, FGMC, FTH, ETS, FTEK) returning to top-50 lists after absences, signal broad retail reengagement and the start of fresh momentum cycles across micro-cap territory. VIX ticked up 5.3% despite the up day, indicating underlying nervousness that contained gains to small-cap pockets rather than a broad-based rally.

Healthcare drove 36% of gainers 5 names returned after long absences CAST · 4-day gainers streak HQ · 4-day gainers streak APGE — first appearance FGMC — first appearance

Market Regime

Mon, Jun 22, 2026 Neutral conf: high macro · prototype

+11

Neutral −100 … +100 · + tailwind / − headwind

VIX17.3 p56 Drawdown-1.8% Held2d · nascent SinceJun 19

Top drivers: Small-cap leadership ▲ S&P drawdown (60d) ▲ S&P vs 50d avg ▲

processId: history-market-regime

Market Indexes

Mon, Jun 22, 2026 13

S&P 500

7,472.79

+41.33

+0.56%

Dow Jones

51,712.71

+510.45

+1.00%

NASDAQ Composite

26,166.60

+277.76

+1.07%

NASDAQ 100

30,347.08

+711.13

+2.40%

DJ US Total Market

74,119.05

+436.01

+0.59%

Russell 1000

4,065.65

+18.55

+0.46%

S&P MidCap 400

3,806.69

+10.37

+0.27%

Russell 2000

3,004.40

+60.41

+2.05%

Russell 2500

1,278.12

+9.60

+0.76%

Russell 3000

4,249.61

+22.59

+0.53%

Nasdaq Financial-100

7,178.24

−18.87

-0.26%

NIFTY 50

24,102.90

+113.75

+0.47%

VIX

17.28

+0.87

+5.30%

Biggest Gainers

Mon, Jun 22, 2026 50

NITO

N2OFF, Inc.Basic Materials

$13.12+$8.04

+158.3%

NASDAQ · Mkt cap $2.9 M

No news headlines were found in the last 48 hours to explain NITO's 158% gain, making the catalyst unclear. The jump likely stems from technical factors, delayed announcement coverage, or market rumors rather than identifiable corporate news.

The absence of recent headlines is notable given the magnitude of the move. A 158% single-day gain for a stock ranked the top gainer suggests either a major corporate event that has not yet been indexed in the news feed provided, a significant technical or short-squeeze event, a delayed announcement from earlier that is now propagating, or unverified market rumors. Without access to company filings, regulatory announcements, or confirmed news sources beyond the Yahoo Finance RSS provided, the precise catalyst cannot be identified. Possible categories include earnings surprise, clinical or regulatory approval if biotech-related, acquisition news, a capital event, or technical/derivative-driven movement. The N2OFF ticker suggests possible involvement in sustainable technology or specialty compounds, but this alone does not explain the move.

NXTS

N2OFF, Inc.Basic Materials

$13.00+$7.92

+155.9%

NASDAQ · Mkt cap $117 K

Nexentis Technologies announced on June 22 that its subsidiary MitoCareX Bio has entered a strategic AI drug discovery partnership with Boltz to accelerate novel small-molecule development, driving the stock up 156% as a likely high-conviction biotech catalyst.

The headlines establish that Nexentis announced a partnership between MitoCareX Bio and Boltz on June 22, 2026, combining MITOLINE-enabled 3D structural modeling with Boltz AI capabilities for virtual screening of transporter targets. The timing aligns perfectly with the stock's intraday surge, suggesting investors view this collaboration as a material development for the company's drug discovery pipeline. The announcement appears credible as a growth catalyst for a small biotech firm, as partnerships integrating advanced AI with proprietary molecular modeling technology often attract investor interest in the discovery-stage biotech space. The magnitude of the move (156%) suggests either this stock trades with high volatility typical of early-stage biotech, or the market had been awaiting this specific announcement. Without prior price history or analyst commentary, we cannot determine whether the move reflects genuine upside surprise or a reversion from an oversold position.

EHGO

Eshallgo Inc. Class A Ordinary SharesIndustrials

$4.06+$2.26

+125.6%

GETY

Getty Images Holdings, Inc.Communication Services

$1.15+$0.54

+90.1%

NYSE · Mkt cap $111 M

Getty Images announced a multi-year licensing deal with OpenAI on June 21, bringing its content into ChatGPT search features, triggering a 90-145% intraday surge as the market priced in new licensing revenue streams.

The news headlines establish a clear, material catalyst: Getty Images signed a licensing partnership with OpenAI that will integrate Getty's visual content into ChatGPT search and discovery experiences. This is a direct revenue-generating contract with one of the most high-profile AI companies, addressing a long-standing question about how AI firms would compensate content creators. For a stock photo and visual content company, this represents both immediate licensing fees and ongoing royalty potential from a major platform. The magnitude of the move—90% closing gain, with intraday swings exceeding 145%—reflects both the market's enthusiasm for newfound monetization of legacy content and likely short covering in a small-cap stock with volatile trading. The timing of the announcement after market close on June 21 and the Reuters/Bloomberg coverage on June 22 explain the full-day rally captured in the snapshot.

TNON

Tenon Medical, Inc.Healthcare

$0.62+$0.27

+77.6%

NASDAQ · Mkt cap $2.4 M

No news headlines were found in the last 48 hours for TNON, so the 77.57% gain likely reflects a technical bounce, delayed news pickup, or retail attention rather than a confirmed corporate announcement.

The absence of any news in the Yahoo Finance RSS feed over the past two days makes it impossible to attribute this 77.57% jump to a specific catalyst. For a micro-cap stock like Tenon Medical trading at $0.62, such moves often reflect one of several patterns: a technical rebound after oversold conditions, delayed market digestion of older news not yet indexed in the feed, short covering if the stock has high short interest, retail trading attention from forums or social media, or general momentum in small-cap medical device or healthcare sectors. Without headline evidence, we cannot distinguish between these scenarios. The stock's low price point also makes it more prone to outsized percentage swings on modest absolute volume.

SKYQ

Sky Quarry Inc.Energy

$1.90+$0.73

+62.4%

NASDAQ · Mkt cap $12 M

Sky Quarry announced it has entered the production phase at Nevada's refinery with 10,000 barrels of inventory and 100,000+ barrels of storage capacity, a major operational milestone that likely drove the 62% gain.

The headline establishes a concrete operational event: Sky Quarry transitioned from development or pre-production status to active production operations at what appears to be Nevada's only refinery facility. The announcement specifies tangible metrics (10,000 barrels on-site, 100,000+ barrel storage capacity), suggesting the company has moved from potential to revenue-generating operations. For a micro-cap stock trading at $1.90, the shift from announced plans to actual production with physical inventory in place represents a material de-risking event. Investors typically reward small-cap industrial or resource companies heavily when they reach operational milestones, particularly the transition to production. The stock's rank as the sixth biggest gainer suggests the market viewed this as significant positive news relative to prior expectations.

DFTX

Mind Medicine (MindMed) Inc.Healthcare

$36.67+$12.19

+49.8%

NASDAQ · Mkt cap $5.1 B

Definium Therapeutics surged nearly 50% after announcing positive Phase 3 trial results for DT120, its LSD-based depression treatment, which met primary endpoints in the Emerge study.

The stock jumped on June 22 following Definium's announcement of positive topline results from its Phase 3 Emerge study evaluating DT120, an orally disintegrating tablet, in adults with major depressive disorder. Multiple sources describe the trial outcome as a "best-case" win and positive result. This is a high-stakes clinical catalyst: Phase 3 success in a late-stage biopharmaceutical program typically drives substantial gains because it materially increases the probability of regulatory approval and eventual commercialization. The company also announced a proposed public offering on the same day, though the primary driver of the rally appears to be the trial success rather than the secondary offering. For a clinical-stage psychedelics biotech, positive Phase 3 efficacy data is the most significant near-term catalyst possible.

CDT

CDT Equity Inc.Healthcare

$1.50+$0.48

+47.1%

APGE

Apogee Therapeutics, Inc.Healthcare

$132.55+$42.17

+46.7%

FGMC

FG Merger Corp.Financial Services

$14.89+$4.59

+44.6%

NASDAQ · Mkt cap $42 M

No news headlines were found in the last 48 hours, so the 44.56% jump in FGMC cannot be tied to a specific announcement. The move is likely driven by a merger or SPAC-related development, technical event, or market rumor not yet captured in the RSS feed.

FGMC is a merger corporation trading at $14.89 with a substantial intraday gain of 44.56%, yet no news appeared in the Yahoo Finance RSS feed over the past 48 hours. For a SPAC or blank-check merger vehicle, typical catalysts include announcement of a target company, shareholder vote approval, deal closing, or changes to merger terms. A 44% move is substantial enough to suggest a material corporate event rather than ordinary trading activity. The absence of news in the headline feed does not mean no announcement occurred; there may be a delay in RSS indexing, or the catalyst may have arrived after market close or via direct SEC filing before media picked it up. Alternatively, the move could reflect technical trading, short covering, or market chatter ahead of an expected announcement.

WYHG

Wing Yip Food Holdings Group Limited American Depositary SharesConsumer Defensive

$6.59+$1.70

+34.8%

NASDAQ · Mkt cap $67 M

No news headlines were found in the last 48 hours, so the 34.76% jump in WYHG cannot be directly attributed to a disclosed event. The move likely reflects a catalyst outside the measured news window, such as an earnings release, insider transaction, short squeeze, or delayed market reaction to an…

Wing Yip Food Holdings is a small-cap food company trading on NASDAQ with an ADR structure. A 34.76% single-day gain ranks it among the top movers, suggesting a significant catalyst. However, the absence of news headlines in the last 48 hours means the trigger either occurred earlier than the news feed captured, emerged through non-traditional channels, or involves technical factors rather than fundamental news. For small-cap food companies, common drivers of sharp moves include quarterly earnings releases (often announced after market close or early morning), acquisition rumors or offers, management changes, or regulatory approvals. Alternatively, the stock may have experienced a short squeeze if it carries elevated short interest, or the move could reflect a delayed market digestion of information released just outside the 48-hour window. Without corroborating headlines, the specific cause remains uncertain.

AZTR

Azitra, Inc.Healthcare

$0.23+$0.06

+34.0%

AMEX · Mkt cap $2.0 M

No news headlines were found in the last 48 hours, so the 34% gain likely reflects technical trading, short covering, or a delayed announcement not yet captured in the RSS feed.

Azitra is a micro-cap stock trading at $0.23 with a significant single-day rally placing it in the top 12 gainers. The absence of recent news headlines in the provided feed does not rule out an actual catalyst; it may indicate the news was released but has not yet appeared in Yahoo Finance's RSS, or the move could be driven by technical factors common to low-priced equities such as short covering, momentum trading, or a press release issued through channels not captured by the snapshot. Biotech and specialty pharma firms in this price range can also move sharply on clinical updates, partnership announcements, or regulatory developments that may take time to propagate through major news aggregators. Without confirmed headlines, attributing the move to any specific event would be speculative.

SAGT

SAGTEC GLOBAL LtdTechnology

$1.31+$0.32

+32.3%

NASDAQ · Mkt cap $13 M

CEO Chen Ng's accumulation of 1.5 million shares alongside FY2026 financial outlook announcement likely signaled confidence in the company's prospects, driving the 32% single-day gain as a vote of insider confidence.

The headline establishes that CEO Chen Ng purchased 1.5 million shares on or near June 22, 2026, concurrent with disclosure of the company's FY2026 financial outlook. Insider accumulation of this magnitude often acts as a positive signal to the market, suggesting leadership believes the stock is undervalued or that near-term fundamentals are improving. The timing coincidence with forward guidance reinforces this interpretation. However, the headline text is truncated and does not provide the actual content of the FY2026 outlook (whether guidance was raised, maintained, or lowered), nor does it confirm whether the outlook itself was positive. The move ranks 13th among daily gainers, suggesting broad market participation rather than isolated insider buying alone, which could indicate the financial outlook itself contained positive details not summarized in the headline snippet.

SMCX

Daily Target 2X Long SMCI ETFFinancial Services

$13.35+$3.17

+31.1%

APLM

Apollomics, Inc.Healthcare

$22.83+$5.33

+30.5%

NASDAQ · Mkt cap $52 M

No news headlines were found in the last 48 hours, so the 30.47% surge likely reflects a delayed earnings report, clinical trial result, FDA decision, or other material event that hasn't yet propagated to major financial news feeds.

Apollomics is a clinical-stage biopharmaceutical company, and a gain of this magnitude without accompanying headlines in the major news feed suggests either a material corporate event occurred but hasn't been widely indexed yet, or the news broke outside the typical financial news cycle. For biotech stocks, the most common catalysts for single-day 30% moves are FDA approvals or clinical trial readouts, partnership announcements, or significant financing events. It is also possible this reflects short covering or technical momentum on lower volume, though that would be speculative. The absence of any news in a 48-hour window around such a large move is notable and suggests checking the company's investor relations page or SEC filings directly would be necessary to identify the actual driver.

FTH

Faeth Therapeutics, Inc.Healthcare

$23.19+$5.37

+30.1%

NASDAQ · Mkt cap $1.0 B

No news was reported in the last 48 hours for Faeth Therapeutics, so the 30% gain likely reflects a delayed market reaction to an earlier announcement, sector momentum, or clinical/regulatory developments not yet captured in the headlines provided.

The absence of any headlines in the last 48 hours is notable given the stock's strong 30% single-day move, which places it among the top 16 gainers on NASDAQ. This disconnect suggests either that the catalyst occurred more than 48 hours ago and was delayed in market pricing, or that material information circulated through channels not yet reflected in the Yahoo Finance RSS feed. For a therapeutic development company like Faeth, typical catalysts include positive clinical trial data, regulatory approvals or positive interactions with the FDA, partnership announcements, or shifts in investor sentiment toward the biotech sector broadly. Without corroborating headlines, we cannot pinpoint which of these categories drove the move. It is also possible that a material announcement was made but not yet indexed by the news aggregator used here.

ETS

Elite Express Holding Inc.Industrials

$0.71+$0.17

+30.1%

NASDAQ · Mkt cap $54 M

No news headlines were found in the last 48 hours, so the 30% gain on June 22 appears driven by technical factors, market rumors, or delayed reporting of company announcements rather than a publicly reported event.

Elite Express Holding Inc. (ETS) jumped 30% on a snapshot date with zero news coverage in the preceding 48 hours. This disconnect between a significant intraday move and an absence of identifiable news suggests several possible explanations. The stock could have experienced technical momentum or a short squeeze, especially if it has high short interest or a thin float typical of smaller-cap NASDAQ stocks. Alternatively, the company may have released news through channels not captured in the Yahoo Finance RSS feed (SEC filings, press releases, or investor relations directly), or the move may have been driven by market rumors or social media activity that preceded formal news dissemination. Without access to real-time intraday headlines, SEC filings from that specific date, or insiders' awareness of company developments, attributing the move to a specific catalyst is not possible based on the evidence provided.

FSHPR

Flag Ship Acquisition Corporation

$0.11+$0.02

+29.6%

NASDAQ

No news headlines were found in the last 48 hours, so the 29.63% gain appears driven by technical factors, short covering, or undisclosed corporate developments not yet reflected in major financial news feeds.

Flag Ship Acquisition Corporation is a SPAC (Special Purpose Acquisition Company), a security class known for volatile price swings driven by merger speculation, shareholder votes, redemption activity, and low float dynamics rather than operational fundamentals. Without any headlines in the past two days, the jump cannot be attributed to announced news. For a SPAC trading at $0.11, the most likely catalysts are either technical bounce-back in a beaten-down name, covering of short positions in a low-liquidity stock, or news that has not yet propagated to major financial news aggregators. SPACs often exhibit outsized single-day moves on thin volume before any formal announcement becomes public. A 29.63% one-day move at this price level and rank is consistent with SPAC microstructure rather than fundamental catalyst.

FTEK

Fuel Tech, Inc.Industrials

$1.99+$0.45

+29.2%

NASDAQ · Mkt cap $44 M

No headlines were reported in the last 48 hours for FTEK, so the 29.22% surge cannot be directly attributed to published news. The jump likely stems from technical buying, institutional interest, or undisclosed news flow.

Fuel Tech (FTEK) gained nearly 30% with zero news coverage in the recent news feeds, which is a notable disconnect. This suggests the catalyst is either not yet reported in mainstream financial news sources, is coming from social media or trading-floor momentum, or reflects a technical reversal in a previously underperforming stock. For a smaller-cap environmental services company like Fuel Tech, potential triggers could include contract announcements, regulatory developments affecting air-quality equipment demand, or positive commentary from analysts or insiders that has not yet propagated to major news outlets. Alternatively, short-covering or a technical breakout from chart-based resistance could drive outsized single-day gains in lower-liquidity names. Without news confirmation, the exact cause remains opaque.

CRMT

America's Car-Mart, Inc.Consumer Cyclical

$3.01+$0.61

+25.4%

NASDAQ · Mkt cap $27 M

No news headlines were found in the last 48 hours for CRMT, so the 25.42% jump likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or an untracked catalyst such as an earnings surprise or insider news that hasn't yet appeared in major news feeds.

America's Car-Mart is a used car dealership and financing company whose stock typically moves on earnings reports, loan portfolio performance, or same-store sales trends. The absence of recent headlines despite a significant intraday gain suggests either a news lag in the RSS feed, a technical rebound after prior weakness, or an internally-announced development that has not yet propagated to public financial news sources. For small-cap auto retailers, used car valuations, credit conditions, and sales volume are primary drivers. The magnitude of the move (top 20 gainer) rules out typical daily volatility and points toward either a discrete company announcement or sustained short-covering, though neither can be confirmed without additional evidence.

JYD

Jayud Global Logistics LimitedIndustrials

$0.83+$0.16

+23.4%

NASDAQ · Mkt cap $8.5 M

No news was reported in the last 48 hours for JYD, so the 23.42% jump on June 22 likely reflects technical trading, retail sentiment, or undisclosed company developments not yet captured in public headlines.

No headlines were found in the Yahoo Finance RSS feed for the last 48 hours surrounding this move. This creates a clear gap between the magnitude of the price action and publicly available information. For a micro-cap logistics company trading below $1, such large single-day moves can reflect several dynamics: retail buying interest possibly driven by social media or message board activity, short covering if the stock had accumulated a significant short position, delayed news from corporate filings or press releases not yet indexed by major news aggregators, or technical factors such as low liquidity amplifying small trades. Without access to intraday trading data, SEC filings, or company press releases issued directly on June 22, it is not possible to identify a specific catalyst. The absence of news does not prove nothing happened; it may mean news exists but was not yet captured by the sources checked.

ENTX

Entera Bio Ltd.Healthcare

$1.48+$0.27

+22.3%

NASDAQ · Mkt cap $153 M

Entera Bio surged 22% after announcing FDA backing for its Phase 3 clinical trial design for EB613, an experimental once-daily oral anabolic tablet for postmenopausal osteoporosis, representing a major regulatory milestone for the company's lead program.

The FDA's positive feedback on Entera's planned Phase 3 trial for EB613 is a clear regulatory catalyst. The agency endorsed the trial design for approximately 750 patients with a 12-month primary endpoint measuring total hip bone mineral density, clearing a significant pathway toward potential New Drug Application submission. For a small-cap biotech like Entera, FDA alignment on late-stage trial design reduces execution risk and validates the therapeutic approach. This type of positive regulatory feedback typically drives investor enthusiasm because it reduces uncertainty about whether the company will need to conduct additional or larger trials, potentially accelerating a path to market. The magnitude of the gain (22% in one day, described as the best day in over five years) suggests this was viewed as a material de-risking event by the market, possibly reflecting pent-up investor interest in the stock or a previous bearish positioning that reversed on this news.

DTSQR

DT Cloud Star Acquisition Corporation

$0.11+$0.02

+22.1%

NASDAQ

No news was published about DTSQR in the last 48 hours, so the 22% gain likely reflects either a technical rebound, a delayed market reaction to an earlier event, or speculative trading activity typical of low-priced SPAC stocks.

The absence of any recent headlines makes it difficult to pinpoint a specific catalyst for today's 22% surge in DTSQR. DT Cloud Star Acquisition Corporation is a blank-check acquisition vehicle (SPAC), and stocks at the $0.11 price level are typically subject to higher volatility and retail speculation. The gain could reflect several scenarios: a technical bounce after earlier selling pressure, anticipation of a merger announcement or business combination that has not yet been formally disclosed to the public, short covering among a thinly traded float, or simply opportunistic buying in a low-priced stock. Without corroborating news or an identifiable corporate event, it is not possible to determine which mechanism drove today's movement.

CAST

FreeCast, Inc. Class A Common StockCommunication Services

$9.84+$1.77

+21.9%

NASDAQ · Mkt cap $100 M

CAST gained 21.93% despite a short-seller report calling the stock overvalued, likely driven by retail investor bullish sentiment and a continuation of momentum from the stock's 420% rally last week rather than new fundamental news.

The headlines present a contradiction that the price action resolves in favor of retail optimism. On June 22, Fugazi Research published a short report claiming FreeCast's stock price is detached from financial reality and questioning the company's business fundamentals across streaming, advertising, telecom, and sports distribution. Simultaneously, the earlier headline notes that retail traders on Stocktwits maintain bullish sentiment with targets suggesting 172% upside potential, and the stock is pulling back after a 420% weekly rally. The 21.93% gain today appears driven by retail momentum and contrarian positioning against the short report rather than by positive company news. This is a classic pattern in micro-cap stocks where sentiment and technical factors can override fundamental criticism.

STG

Sunlands Technology GroupConsumer Defensive

$4.15+$0.74

+21.7%

NYSE · Mkt cap $42 M

No news headlines were found in the last 48 hours, so the 21.7% jump cannot be attributed to a specific announced catalyst; the move likely reflects technical trading, short covering, or an off-exchange event not yet reported.

Yahoo Finance returned no headlines for Sunlands Technology Group in the past two days, leaving the cause of the 21.7% gain unexplained by disclosed corporate events. For a smaller-cap stock like STG trading at $4.15, significant single-day moves without matching news often stem from technical factors such as short covering, algorithmic trading triggered by price momentum or volume spikes, or speculative retail interest. Another possibility is that news existed but was not yet indexed by the RSS feed at the time of this snapshot, or the catalyst was an after-hours announcement, insider trading signal, or industry-wide sector rotation. Without substantive reporting, attributing the move to fundamentals or specific events would be pure speculation.

CANG

Cango Inc.Financial Services

$0.23+$0.04

+21.6%

NYSE · Mkt cap $69 M

No news headlines were found in the last 48 hours to explain CANG's 21.58% jump on June 22, 2026, so the catalyst remains unclear from available public information.

The absence of any recent news headlines makes it difficult to pinpoint a specific catalyst for this 21.58% move in CANG. Cango Inc. is an automotive transaction services platform, and a penny stock at $0.23 may be prone to technical trading activity, short covering, or reactions to delayed earnings releases or guidance updates that may not yet have reached major news feeds. Alternatively, the jump could reflect broader market sentiment shifts, social media discussion, or accumulation by retail investors in lower-priced equities. Without corroborating headlines or company announcements, any explanation remains speculative. The 48-hour news gap is notable and suggests either the move preceded major news distribution or was driven by non-news factors.

RTB

RTB Digital IncTechnology

$12.46+$2.21

+21.6%

NASDAQ · Mkt cap $181 M

RTB Digital jumped 21.56% on June 22 with no news headlines in the last 48 hours, making the specific catalyst unclear and suggesting either delayed news pickup, technical factors, or market-moving developments not yet reflected in publicly available headlines.

No recent news headlines were available from Yahoo Finance within the 48-hour window preceding this significant gain, which presents a challenge in pinpointing the exact driver. A 21.56% single-day move for a stock ranking 27 among daily gainers is substantial and typically warrants a catalytic event. Given the absence of reported headlines, several categories of causes are plausible: RTB Digital may have announced earnings, guidance, a partnership, or strategic update that has not yet been indexed by the news feed; technical factors such as short covering, options expiration dynamics, or accumulated buying pressure from a previous day's after-hours news could be at play; or market participants may be reacting to insider activity, analyst upgrades, or sector-wide momentum shifts. Without access to the underlying newswire or company filings from June 22, attribution remains speculative.

NIXX

Nixxy, Inc.Communication Services

$1.42+$0.25

+21.4%

NASDAQ · Mkt cap $21 M

Nixxy Inc. announced an offtake agreement with Nidar Infrastructure Limited for a $156 million annual revenue platform and up to 1 GW of grid-independent AI infrastructure powered by North Dakota natural gas, triggering the 21.37% intraday gain.

The news headline indicates Nixxy secured a significant commercial offtake agreement involving substantial revenue commitments and infrastructure capacity for AI operations. This type of announcement—a named, quantified partnership with explicit revenue and capacity targets—typically catalyzes gains in early-stage infrastructure or energy-tech stocks because it demonstrates revenue visibility, de-risks business model execution, and validates management's strategic direction. The $156 million annual revenue figure and 1 GW capacity scale suggest a material contract for a company trading near $1.42, which is consistent with the magnitude of the move. The agreement appears to have been announced on the snapshot date itself, explaining the same-day rally.

RFIL

RF Industries, Ltd.Industrials

$21.50+$3.69

+20.7%

NASDAQ · Mkt cap $127 M

No news headlines were found in the last 48 hours to explain RFIL's 20.72% surge, so the driver remains unclear; the jump may reflect delayed market reaction to an earlier announcement, technical trading, or a catalyst not yet indexed by Yahoo Finance.

RF Industries experienced a substantial single-day gain of over 20% with no corresponding news coverage in the recent headlines feed. This absence of news is noteworthy because a move of this magnitude typically follows a material catalyst such as an earnings announcement, contract win, guidance raise, or strategic update. There are two plausible explanations: first, the catalyst may have been released before the 48-hour window or late enough that newswires have not yet picked it up by the snapshot time; second, the move could reflect short covering, technical breakout buying, or reaction to rumors not yet formalized into reportable news. RF Industries is a manufacturer of interconnect products and components with moderate market capitalization, the type of stock that can experience sharp intraday swings on supply-chain news or orders, but without direct confirmation from headlines the root cause remains speculative.

Horizon Quantum Holdings Ltd. Class A Ordinary SharesTechnology

$38.39+$6.39

+20.0%

NASDAQ · Mkt cap $905 M

HQ jumped 19.97% on June 22, but the only recent headline is a June 20 valuation analysis suggesting 49% upside—a bullish frame that may have reignited retail interest, though no specific catalyst news was disclosed in the provided feed.

The single headline from June 20 argues that HQ stock at US$32 was undervalued relative to fair value, implying substantial upside potential. This analyst commentary appears to have coincided with or preceded a sharp two-day rally that pushed the stock to $38.39. However, the headline itself is retrospective commentary on valuation, not a forward-looking catalyst announcement such as a partnership, earnings beat, product milestone, or clinical trial result. For an early-stage quantum software company, typical drivers of large single-day moves include proof-of-concept announcements, major customer wins, strategic partnerships, funding rounds, or insider activity. The timing and magnitude of today's gain suggests either algorithmic response to the valuation piece, retail momentum following the headline, or an undisclosed event not captured in the provided news feed.

NVCT

Nuvectis Pharma, Inc.Healthcare

$16.53+$2.71

+19.6%

CENN

Cenntro Electric Group LimitedConsumer Cyclical

$3.95+$0.64

+19.3%

NASDAQ · Mkt cap $9.0 M

No news headlines were available in the last 48 hours for Cenntro Electric, so the 19.34% jump cannot be attributed to a specific announced event. The move likely reflects either technical trading activity, a delayed market reaction to an untracked development, or sector-level momentum.

The absence of recent news headlines makes it impossible to pinpoint a concrete catalyst for this substantial single-day gain. Cenntro is a microcap electric vehicle company, a sector historically prone to retail trading interest and volatility spikes driven by technical factors or social media attention rather than fundamental news. The stock's rank as the 32nd biggest gainer suggests broad-based momentum rather than a company-specific announcement. Possible explanations include a positive technical breakout, renewed investor interest in the EV sector, an untracked press release or regulatory filing, or short-squeeze dynamics common in lower-liquidity names. Without corroborating headlines or corporate announcements visible here, any explanation remains speculative.

SSTK

Shutterstock, Inc.Communication Services

$15.71+$2.49

+18.8%

NYSE · Mkt cap $204 M

Getty Images announced a major OpenAI licensing deal and surged 145% on the same trading day, likely triggering a sector-wide rally in stock-photo and digital content companies, lifting SSTK as a direct competitor in the same space.

Getty Images' announcement of a licensing agreement with OpenAI on June 22 represents a significant validation event for the stock-photo licensing industry. The massive 145% surge in Getty reflects investor excitement about monetizing content for AI training and use. SSTK, as Shutterstock, operates in the nearly identical business—licensing digital imagery to creators and enterprises. When a sector leader experiences a dramatic move tied to a concrete new revenue stream (AI licensing deals), competitors typically follow higher on the same day as investors reassess the entire category's growth prospects. This pattern is reinforced by the fact that SSTK is one of the largest players in the same market. The secondary headline about profitable companies and lasting business models is unrelated to today's move. No company-specific news about SSTK itself was provided, so the move appears to be sectoral spillover rather than SSTK-specific fundamentals.

SMHI

SEACOR Marine Holdings Inc.Industrials

$7.93+$1.25

+18.7%

NYSE · Mkt cap $265 M

SEACOR Marine's largest independent shareholder, Jorey Chernett (7.2% stake), publicly called on the board to evaluate strategic alternatives including a sale or dual-track fleet disposition, triggering the +18.71% rally as investors priced in increased M&A probability.

The headline establishes that a major activist shareholder has formally pushed for a strategic review, which is a concrete catalyst for a stock up 18.71% in a single day. Chernett's call for either an outright company sale or a structured fleet sale represents material pressure on management to unlock value, a classic activist playbook. This type of announcement typically triggers positive re-rating because it signals potential liquidity events, asset sales at favorable valuations, or takeout bids that may exceed current market price. The timing and prominence of the statement—delivered on the snapshot date itself—aligns perfectly with the intraday surge. No conflicting or offsetting news was provided, so the causation appears direct.

ORIS

ORIENTAL RISE HOLDINGS LtdConsumer Defensive

$2.42+$0.38

+18.6%

NASDAQ · Mkt cap $545 K

No news headlines were found in the last 48 hours, so the 18.63% gain cannot be directly attributed to a disclosed event; the move is likely driven by technical factors, delayed news, or market rumors.

Oriental Rise Holdings saw a significant single-day rally of 18.63%, landing it as the 35th biggest gainer on the day. However, the Yahoo Finance RSS feed returned no headlines in the preceding 48 hours that would explain this move. This creates a gap between the price action and publicly available news coverage. Several generic categories could explain such a move in a lower-priced stock like ORIS: technical short-covering or reversal, delayed reporting of corporate announcements not yet picked up by major news feeds, rumors or social media momentum, sector-wide tailwinds, or opportunistic retail buying. Without access to company filings, press releases, or real-time market data beyond the headline search, we cannot determine which of these applies. The absence of news in the last 48 hours does not rule out an announcement earlier in the week or an intraday event that has not yet been indexed by the RSS feed.

XCUR

Exicure, Inc.Healthcare

$2.74+$0.43

+18.6%

NASDAQ · Mkt cap $9.5 M

No news headlines were found in the last 48 hours for XCUR, so the +18.61% gain likely stems from technical momentum, short covering, or a delayed market reaction to an earlier announcement not yet reflected in this feed.

Exicure (XCUR) jumped 18.61% on June 22, 2026, but no recent news headlines appear in the Yahoo Finance RSS for the prior 48 hours. This absence of contemporaneous news makes direct attribution difficult. For a small-cap biotech stock like Exicure, typical catalysts include clinical trial results, partnership announcements, FDA feedback, or changes in cash position. The magnitude of the gain (nearly 19%) suggests either a discrete positive event that has not yet appeared in headline feeds, a short squeeze or technical breakout after a period of weakness, or a delayed market response to news released earlier but only now gaining traction. Without verifiable headline evidence, we cannot pinpoint the specific cause, only that the timing does not align with any identified news release in the available 48-hour window.

ORKA

Oruka Therapeutics, Inc.Healthcare

$85.38+$13.04

+18.0%

NASDAQ · Mkt cap $6.5 B

No headlines were published in the last 48 hours, so the cause of ORKA's 18% gain cannot be determined from news. The move likely reflects either a delayed market reaction to an earlier announcement, an untracked corporate event, or technical trading activity.

The absence of recent headlines makes it impossible to anchor the 18% move to a specific catalyst. For a biotech company like Orka Therapeutics, typical drivers of single-day rallies include clinical trial results, regulatory approvals or guidance changes, partnership announcements, or analyst upgrades. Without evidence in the provided news feed, the jump may reflect: (1) a press release or announcement made outside the Yahoo Finance RSS window, (2) a reaction to competitor or sector news that lifted Orka indirectly, or (3) technical factors such as short covering or repositioning. The magnitude of the move (37th largest gainer) suggests a material event rather than random drift, but that event remains unidentified in the available sources.

SAFX

XCF Global, Inc. Class A Common StockUtilities

$0.49+$0.07

+17.8%

NASDAQ · Mkt cap $141 M

No news headlines were available in the last 48 hours to explain SAFX's 17.76% gain, so the driver remains unclear; the move may reflect technical trading, a delayed market reaction, or undisclosed company developments.

SAFX gained 17.76% to $0.49 on June 22, 2026, but no news articles were indexed in the Yahoo Finance RSS feed for the preceding 48 hours. This absence of contemporaneous headlines makes it impossible to attribute the move to a specific catalyst such as earnings, guidance, partnerships, regulatory approval, or major executive changes. For a micro-cap equity trading near fifty cents, typical drivers of single-day double-digit moves include short-squeeze dynamics, technical breakouts from support or resistance levels, options-driven volatility, retail trading coordination, or delayed disclosure of material company events that may not yet have broad press coverage. Without access to intraday order flow, company filings, or social media sentiment, any explanation would be speculative. The stock's low price and rank as 38 biggest gainer suggest it may be a volatile, thinly traded security where small absolute share movements can generate large percentage gains.

VHUB

VenHub Global, Inc. Common StockConsumer Defensive

$1.35+$0.20

+17.4%

NASDAQ · Mkt cap $42 M

No news headlines were found in the last 48 hours, so the 17.39% gain on VHUB likely reflects technical trading, a delayed market reaction to an earlier announcement, or sector momentum rather than a identifiable catalyst.

The absence of any recent news coverage makes it difficult to pinpoint a specific event driving the move. VenHub Global is a small-cap NASDAQ stock, and stocks at this price level and market cap are often subject to technical factors, short-covering rallies, retail trading activity, or delayed reactions to older announcements that Yahoo Finance's RSS feed may not have captured. It is also possible the move reflects sector-wide momentum in whatever industry VenHub operates in, or insider activity not yet publicly disclosed. Without access to intraday order flow, SEC filings released today, or news from other sources, the exact catalyst remains opaque.

INCR

InterCure Ltd.Healthcare

$1.09+$0.16

+17.4%

NASDAQ · Mkt cap $55 M

InterCure secured NIS 22 million in private placement financing led by pharma-focused hedge funds and backed by the CEO, which likely triggered the 17.37% gain as a vote of confidence in the company's direction and financial runway.

The headline establishes that InterCure completed a private placement financing round totaling NIS 22 million on June 22, 2026. The funding was led by established pharma-focused hedge funds including Bennu Pharma Fund Ltd., and notably included commitments from the company's CEO Alexander Rabinovich and other key shareholders. For a micro-cap trading at $1.09, a capital infusion of this scale typically signals several positive catalysts: (1) validation of the business model and pipeline by sophisticated pharma investors, (2) near-term solvency and ability to execute on clinical or commercial milestones, and (3) insider confidence reflected in management's personal investment. The timing and composition of the investor syndicate suggest institutional conviction rather than distressed financing. This aligns with typical stock reactions to equity raises by well-regarded specialist investors in the biotech space.

MGRT

Mega Fortune Company LimitedTechnology

$83.93+$11.98

+16.7%

NASDAQ · Mkt cap $1.3 B

No news headlines are available for MGRT in the last 48 hours, so the 16.65% gain on June 22 cannot be attributed to a specific announced event. The move is likely driven by technical factors, delayed news dissemination, or market rumors.

The absence of recent news coverage for a 16.65% single-day jump is notable and creates genuine ambiguity about causation. Without access to company filings, insider trading alerts, or real-time social media sentiment, several generic categories remain possible: a technical bounce after oversold conditions, options expiration effects, short covering, or breaking news that has not yet been indexed by the RSS feed provided. For smaller or less-liquid NASDAQ stocks like MGRT, isolated 15%+ moves can reflect thin liquidity amplifying modest fundamental shifts. Without knowing the company's sector, market capitalization, or recent price trends, pinpointing the catalyst is not feasible. The gap between price action and available news headlines suggests either a timing lag in reporting or a non-news-driven catalyst.

ATON

AlphaTON Capital Corp.Healthcare

$0.29+$0.04

+16.6%

NASDAQ · Mkt cap $667 K

No news headlines were found in the last 48 hours, so the 16.56% intraday gain cannot be directly attributed to a specific announced event; the driver remains unclear without additional information.

ATON showed a strong single-day gain of 16.56% on June 22, 2026, yet zero news items appeared in the Yahoo Finance RSS feed over the prior 48 hours. This absence of reported catalysts makes attribution difficult. However, penny stocks and thinly traded securities like those trading at $0.29 are susceptible to several types of moves independent of news: technical rebounds after oversold conditions, short covering, retail momentum plays, delayed announcements not yet picked up by major feeds, or rumors in message boards or smaller channels. Without headline confirmation or known structural facts about ATON's status as a SPAC, shell company, or other special security type, the specific driver cannot be identified from the evidence at hand.

WYFI

WhiteFiber, Inc. Ordinary SharesTechnology

$44.77+$6.28

+16.3%

NASDAQ · Mkt cap $730 M

A bullish investment thesis on WYFI published on TradersPro's Substack appears to have driven the 16.32% gain, though the headline does not detail the specific argument or catalyst that prompted the positive call.

The only news item in the 48-hour window is a summary article asking whether WYFI is a good stock to buy, followed by mention of a bullish thesis circulating on TradersPro's Substack. The article snippet provided does not reveal the actual argument or fundamental catalyst behind the bullish case, only that one exists and was published around the time of the price move. It is reasonable to infer that third-party investment commentary highlighting positive attributes of the stock may have attracted retail or institutional interest, but without the underlying thesis details, we cannot determine whether the call was based on a specific corporate development, technical setup, valuation opportunity, or other factor. The timing of the article publication (12:30 UTC on 2026-06-22) aligns reasonably with intraday momentum, though causation cannot be confirmed.

RGNX

REGENXBIO Inc.Healthcare

$9.07+$1.27

+16.3%

NASDAQ · Mkt cap $543 M

The FDA agreed to reconsider Regenxbio's application for Navsunli, its experimental gene therapy for Hunter syndrome (MPS II), reversing a prior rejection and opening a path to accelerated approval, driving a strong 16% rally in the stock.

On June 22, 2026, Regenxbio announced it had achieved alignment with the FDA on the resubmission pathway for Navsunli (clemidsogene lanparvovec-sn), a gene therapy candidate for MPS II. The FDA had previously rejected the application, but this announcement signals the agency has reconsidered and agreed on next steps toward potential accelerated approval. This reversal is material for a clinical-stage gene therapy company because it removes a significant regulatory barrier and restores a path to market for a potentially first-in-class treatment. The timing aligns with broader FDA efforts to clear backlog rejections from prior administrations that may have contradicted earlier agreements. The broader healthcare sector was also modestly higher that day, providing some tailwind, but the RGNX move significantly outpaces sector gains, indicating the news was company-specific and positive.

BWIN

The Baldwin Insurance Group, Inc.Financial Services

$23.52+$3.28

+16.2%

NASDAQ · Mkt cap $3.0 B

BWIN surged 16.21% on above-average volume, but the provided headlines contain no specific catalyst—only vague references to the move itself and unrelated Wall Street calls. The cause remains unexplained by available news.

The first headline acknowledges BWIN's 16.8% jump and heavy trading volume but explicitly states that "the latest trend in earnings estimate revisions for the stock doesn't suggest further strength," indicating no positive earnings revision drove the move. The second headline about SpaceX and Apple is completely unrelated to BWIN. No M&A, guidance change, regulatory decision, or other concrete corporate event is mentioned in the provided news. This leaves the cause unclear from the available headlines. Insurance stocks can move on underwriting trends, reserve adjustments, dividend announcements, or analyst upgrades, but none of these are documented here. Absent a specific trigger in the news, the move could reflect technical factors, a delayed announcement not yet captured in these feeds, or market sentiment shifts within the insurance sector.

AVTX

Avalo Therapeutics, Inc.Healthcare

$17.08+$2.38

+16.2%

JAGX

Jaguar Health, Inc.Healthcare

$2.61+$0.36

+16.0%

NASDAQ · Mkt cap $4.5 M

Jaguar Health announced it is exploring strategic alternatives and will provide updates on its crofelemer development program for rare intestinal failure at an investor forum on June 24, likely driving optimism about potential partnerships or clinical progress.

The company issued a press release on June 22 announcing plans to explore strategic alternatives aligned with a targeted NDA filing for its rare disease intestinal failure program. CEO Lisa Conte is scheduled to present at the Life Sciences Virtual Investor Forum on June 24 to provide updates on the crofelemer development program. This announcement suggests potential near-term catalysts such as regulatory progress, partnership discussions, or business development activity. The 16% single-day gain is consistent with biotech investors reacting positively to forward momentum in a clinical development program and management's explicit commitment to evaluate strategic options. The general healthcare sector strength that day provided tailwind, but the company-specific news about strategic exploration appears to be the primary driver for JAGX's outperformance.

CGTX

Cognition Therapeutics, Inc.Healthcare

$1.68+$0.23

+15.9%

NASDAQ · Mkt cap $93 M

No headlines were found in the last 48 hours, so the 15.86% gain cannot be directly attributed to disclosed news. The move likely reflects technical buying, delayed news impact, or small-cap volatility.

Cognition Therapeutics is a small-cap biotech stock, and NASDAQ gainers of this magnitude with zero recent headline coverage typically reflect one of several patterns: late disclosure of company news not yet picked up by major feeds, technical or algorithmic buying triggered by a price threshold or volume signal, delayed market reaction to older news, sector rotation into biotech, or simple small-cap volatility. Biotech stocks of this size are particularly prone to outsized daily swings on modest volume. Without confirmed news, attribution remains speculative. The stock's rank as the 48th biggest gainer despite no visible catalyst suggests either the news infrastructure is lagging the market or the move is driven by technical factors rather than fundamental disclosure.

OTLK

Outlook Therapeutics, Inc.Healthcare

$1.83+$0.25

+15.8%

NASDAQ · Mkt cap $167 M

No news headlines were found in the last 48 hours, so the 15.82% gain is unexplained by public announcements. The move likely reflects technical trading, delayed news, or market rumors in a low-priced biotech stock.

Outlook Therapeutics is a small-cap ophthalmology-focused biopharmaceutical company, and no material news was identified in the Yahoo Finance RSS feed over the past two days. However, stocks in this category, especially those trading near $2, are susceptible to several common drivers of sharp single-day moves: delayed publication of clinical trial results or regulatory decisions, short-covering or technical breakouts above key resistance levels, or retail trading activity responding to social media or message boards. Biotech stocks are also prone to gap moves on overnight news that may not yet be reflected in mainstream financial feeds. Without a specific catalyst in the headlines, it is reasonable to infer that either news exists but has not yet propagated to the tracked sources, or the move is driven by technical factors or sentiment rather than fundamental disclosure.

FRGT

Freight Technologies, Inc.Technology

$4.41+$0.60

+15.7%

NASDAQ · Mkt cap $1.0 M

No news was found in the last 48 hours for FRGT, so the 15.75% gain likely reflects either delayed market reaction to an earlier announcement, intraday technical momentum, or untracked sector/thematic catalysts in freight logistics.

The absence of recent Yahoo Finance headlines within 48 hours of this major 15.75% single-day move makes direct causation difficult to establish. For a micro-cap or lower-volume stock like FRGT trading at $4.41, price swings of this magnitude can result from several common drivers not always captured by headline feeds: a delayed market reaction to company releases published outside the news aggregation window, technical or algorithmic buying after breaking above a resistance level, sector-wide momentum in logistics or freight technology, short covering if the stock has elevated short interest, or untracked social media or message board activity. Without access to pre-market news, earnings calendars, or company press releases directly, the specific catalyst remains unidentified. The stock's rank as the 50th biggest gainer suggests genuine volume participation rather than pure illiquidity effects.

Biggest Losers

Mon, Jun 22, 2026 50

AIXI

Xiao-I CorporationTechnology

$3.06−$3.20

-51.1%

NASDAQ · Mkt cap $654 K

No news headlines were available in the last 48 hours to explain AIXI's 51% collapse, the largest single-day loss on NASDAQ that day. The cause remains unknown without additional information.

The absence of any news coverage in the Yahoo Finance RSS feed over the preceding two days makes it impossible to identify a specific catalyst for this severe decline. A 51% single-day loss typically signals either a major negative corporate announcement (earnings miss, guidance slash, leadership change, regulatory action), a significant market-wide shock that disproportionately hit this stock, or a technical event such as a halt followed by a gap-down open. For a smaller-cap artificial intelligence or technology company like Xiao-I, common triggers include disappointing quarterly results, loss of a major client or contract, licensing disputes, or short squeezes unwinding. Without access to intra-day trading patterns, after-hours news, or company filings posted on June 22 itself, the specific catalyst cannot be determined from the evidence available.

LICN

Lichen International LimitedIndustrials

$1.21−$0.96

-44.2%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, so the 44% drop on June 22 cannot be directly attributed to a specific announced event; the catalyst may involve a delayed earnings report, insider trading activity, analyst downgrade, or broader market pressure on micro-cap stocks.

The absence of recent news headlines makes it difficult to pinpoint the exact cause of LICN's sharp 44% decline. Lichen International is a small-cap stock trading below $1.50, which typically means it has lower analyst coverage and less frequent news flow than larger companies. Possible categories of catalyst for this magnitude of move include: delayed or poor quarterly earnings announcement that hit the wire before or after the news aggregator captured it; a significant analyst downgrade or rating withdrawal; insider selling or a secondary offering; negative developments in the company's core business operations that spread via other channels before reaching major news feeds; or broader sell-off pressure on micro-cap and penny-stock sectors. Without specific headlines, we cannot rule out technical selling, short-covering reversal, or even a rumors and social media-driven move.

SDOT

Sadot Group Inc.Consumer Defensive

$9.25−$6.93

-42.8%

NASDAQ · Mkt cap $11 M

No news headlines were found in the last 48 hours for SDOT, so the 42.83% single-day crash cannot be directly attributed to a disclosed event. The move likely stems from an undisclosed catalyst such as earnings disappointment, insider selling, debt distress, or market rumor.

The absence of any news in Yahoo Finance's RSS feed over the past 48 hours is notable given the severity of the move. A decline of this magnitude on a major exchange typically correlates with a material corporate event, regulatory action, or sudden shift in investor sentiment. For a smaller-cap NASDAQ stock like SDOT, possible drivers include unannounced earnings results or guidance revision, sudden insider transactions, covenant breach or liquidity concern, competitive threat, or sector-wide selloff that caught specific exposure. The lack of visible headlines does not rule out social media rumors, private investor alerts, or delayed news aggregation on less-followed stocks. Without access to after-hours announcements, SEC filings from the past 24 hours, or real-time Twitter commentary, the precise cause remains opaque.

SNBR

Sleep Number CorporationConsumer Cyclical

$0.13−$0.08

-39.7%

NASDAQ · Mkt cap $611 K

No news headlines were found in the last 48 hours to explain the 39.67% drop in Sleep Number stock, suggesting the decline was driven by either delayed reporting of company announcements, broader market conditions, or an undisclosed catalyst.

The absence of any news headlines in the provided RSS feed within the last 48 hours makes it impossible to identify a specific catalyst for this severe 39.67% decline. Given the magnitude of the move and the stock's current price of $0.13, several categories of events could explain such a sharp drop: a negative earnings announcement or major guidance cut, disclosure of material financial distress or covenant violations, executive departures, loss of a major customer or contract, or sector-wide headwinds affecting specialty furniture and bedding retailers. Sleep Number operates in a cyclical consumer discretionary segment sensitive to macroeconomic conditions and consumer spending, so broader economic weakness could also contribute. Without corroborating headlines or official filings referenced, we can only categorize the likely types of catalysts rather than identify the specific event.

JLHL

Julong Holding Limited Class A Ordinary SharesIndustrials

$26.45−$13.24

-33.4%

NASDAQ · Mkt cap $152 M

No news headlines were published in the last 48 hours, so the cause of the 33.36% drop cannot be determined from available information. The move likely reflects either a significant corporate announcement not yet captured by major news feeds, a technical event, or market reaction to external fact…

Despite a severe single-day decline placing JLHL among the top five losers on NASDAQ, no news headlines appear in the Yahoo Finance RSS feed for the prior 48 hours. This absence of reported catalyst is notable given the magnitude of the move. Possible explanations include: (1) a material announcement (earnings miss, guidance cut, insider departure, regulatory action, or financing dilution) that has not yet been picked up by major news aggregators, or (2) a technical or momentum-driven sell-off unconnected to breaking news, perhaps triggered by a pre-existing catalyst from earlier in the week or by market-wide conditions. For a lower-liquidity or micro-cap security like a Chinese holding company traded via ADR, news dissemination delays are possible, as is the occurrence of material events announced through non-English channels or company filings that precede media coverage.

LOFF

Direxion Daily SpaceX Bull 2X ETF

$21.31−$10.48

-33.0%

AMEX

No relevant news headlines were found in the last 48 hours, but LOFF is a 2X leveraged inverse ETF tracking SpaceX equity movements, so a sharp decline likely reflects either a major drop in SpaceX's valuation, forced liquidations in leveraged vehicles, or a significant negative catalyst in the s…

The absence of any news in the Yahoo Finance RSS feed over the past 48 hours makes it impossible to identify a specific corporate or market event that triggered this 32.97% decline. However, LOFF's structure as a daily 2X leveraged bull ETF tied to SpaceX means the underlying SpaceX equity or SpaceX-related sector sentiment likely experienced substantial deterioration. Leveraged ETFs can also experience decay or suffer from forced selling during volatile market conditions. Given that LOFF ranked as the sixth biggest loser of the day, the move appears market-wide rather than isolated to news coverage gaps. The most likely categories of catalyst are either a sharp SpaceX-specific negative development (valuation reset, major contract cancellation, regulatory action, or leadership change) or a broader sector selloff in space-related equities, neither of which has surfaced in tracked headlines as of the snapshot date.

SPAX

T-REX 2X Long SpaceX Daily Target ETFFinancial Services

$12.85−$6.25

-32.7%

SPCF

Proshares Ultra Spacex

$21.36−$10.26

-32.4%

AMEX

No news was reported in the last 48 hours, but SPCF is a 3x leveraged ETF tracking SpaceX; a 32% drop likely reflects a sharp decline in the underlying SpaceX valuation or broader market stress amplified by the fund's leverage structure.

The absence of any headlines in the search window means we cannot identify a specific company announcement, regulatory event, or market catalyst. However, SPCF is structurally a leveraged inverse or ultra-long position on SpaceX equity, designed to amplify daily moves. A 32% single-day loss on a leveraged vehicle typically reflects either a significant drop in the underlying asset (SpaceX's private valuation or related proxy movers) or a market-wide selloff. Since SpaceX is privately held, moves in SPCF may correlate with broader aerospace, defense, or growth-sector declines, secondary market transactions, or sentiment shifts in late-stage private equity. The lack of reported news does not rule out a private transaction, valuation markdown, or delayed reporting of an earlier announcement. Leveraged ETFs also reset daily, so multi-day volatility can compound losses in ways that differ from the underlying.

SMCZ

Daily Target 2X Short SMCI ETF

$6.45−$2.97

-31.5%

NASDAQ

No news emerged in the last 48 hours, but SMCZ is a 2X inverse leveraged ETF on Super Micro Computer (SMCI), so a sharp 31.5% loss suggests SMCI surged roughly 15-16% on positive momentum or company-specific news.

SMCZ is a daily target 2X short leveraged ETF, meaning it moves inversely to SMCI and amplifies moves by a factor of two. The 31.5% drop in SMCZ implies SMCI rallied significantly. While no headlines were found in the 48-hour window provided, leveraged inverse ETFs decline sharply when their underlying asset rises. The cause of SMCI's rally could be positive earnings, guidance, a major contract award, a sector tailwind, or short-covering momentum. Without access to SMCI-specific news or broader semiconductor sector catalysts on June 22, 2026, the exact trigger cannot be identified from the data provided. The structure of the instrument itself explains why SMCZ fell, but the root cause of SMCI's strength remains unknown.

INLF

INLIF LimitedIndustrials

$0.11−$0.05

-29.1%

NASDAQ · Mkt cap $5.2 M

No news headlines were available in the last 48 hours to explain INLIF's sharp 29% decline on June 22, 2026, so the cause remains unknown without additional reporting.

INLIF Limited experienced a significant single-day drop to $0.11 with no identifiable news catalyst in the provided headlines from the past two days. At such a low price point, INLIF may be a micro-cap or penny stock, which are known for elevated volatility and susceptibility to technical factors, short-covering, or delayed news dissemination. The absence of headlines does not rule out a real corporate event—delisted earnings reports, insider transactions, regulatory filings, or clinical trial results from biotech or pharmaceutical companies often move penny stocks sharply before major news outlets report them. Alternatively, the decline could reflect technical selling pressure, margin calls, or sector-wide weakness in small-cap equities. Without access to real-time news feeds, SEC filings, or company press releases beyond the Yahoo Finance RSS window, pinpointing the specific trigger is not possible.

AEMD

Aethlon Medical, Inc.Healthcare

$1.38−$0.51

-27.0%

NASDAQ · Mkt cap $1.5 M

No news headlines were found in the last 48 hours, so the 27% drop likely stems from a company announcement, clinical setback, financing event, or market-wide sector pressure not yet captured in the RSS feed.

Aethlon Medical is a small-cap medical device company focused on blood purification and infectious disease applications. With no news in the Yahoo Finance RSS over the last 48 hours, the sharp 27% decline is not directly attributable to a publicly announced catalyst visible in the provided data. However, small-cap biotech and medical device stocks are sensitive to clinical trial results, regulatory feedback, capital raises, insider selling, or sector rotations. Given the magnitude of the move, the most likely categories of cause are either a delayed press release or SEC filing not yet indexed by the feed, deterioration in cash position forcing dilutive financing, a negative clinical or regulatory development, or broader sector pressure in medical device stocks on the snapshot date. Without contemporaneous news, any specific explanation would be speculation.

GAUZ

Gauzy Ltd. Ordinary SharesTechnology

$0.48−$0.16

-24.9%

NASDAQ · Mkt cap $6.9 M

No news headlines were found in the last 48 hours, so the 24.91% drop likely reflects a delayed market reaction to an earlier event, technical selling pressure, or a rumor not yet captured in the RSS feed.

Without any recent headlines in the provided news feed, the cause of GAUZ's sharp decline cannot be directly attributed to a specific corporate announcement, earnings release, or regulatory action. Gauzy is a specialty materials and technology company, and stocks in this category can be sensitive to shifts in demand forecasts, supply chain disruptions, or broader market sentiment toward the industrial or advanced materials sector. The stock's low absolute price ($0.48) and relatively small market capitalization make it more prone to both algorithmic selling and volume-driven moves that may not require major news to trigger. It is also possible that relevant news exists but has not yet propagated to the Yahoo Finance RSS feed used in this analysis, or that the move reflects a delayed market reaction to information released outside the standard 48-hour window.

HSPT

Horizon Space Acquisition II Corp.Financial Services

$4.48−$1.31

-22.6%

ODVWZ

Osisko Development Corp. Warrant expiring 5/27/2027Basic Materials

$0.07−$0.02

-22.2%

NASDAQ

No news headlines were available in the last 48 hours to explain the 22% decline, but warrant expiration decay and underlying stock weakness are typical drivers of this class of security.

No recent news was found in the Yahoo Finance RSS feed for the last 48 hours, so there is no specific headline-driven catalyst to identify. However, ODVWZ is a warrant expiring 5/27/2027, a derivative security highly sensitive to two factors: the price movement of the underlying Osisko Development stock and time decay as expiration approaches. Warrants lose value as they approach maturity if the underlying stock does not move higher, and any weakness in Osisko Development itself or deteriorating sentiment in junior mining exploration stocks would compress warrant value rapidly. The 22% single-day loss is consistent with either a sharp selloff in the underlying or a volatility-driven repricing, but without confirmed news or access to Osisko's stock action that day, we cannot pinpoint the specific trigger. Market-wide mining sector weakness or company-specific news not yet reflected in the news feed are plausible causes.

AHMA

Ambitions Enterprise Management Co. L.L.CConsumer Cyclical

$1.85−$0.52

-21.9%

NASDAQ · Mkt cap $46 M

No news headlines were found in the last 48 hours for AHMA, so the 21.94% drop cannot be directly attributed to a specific announced event; the decline likely stems from technical selling, delayed news absorption, or broader market conditions.

The absence of any recent news in the Yahoo Finance RSS feed over the past 48 hours makes it impossible to tie the sharp 21.94% decline to a concrete catalyst. For a micro-cap stock like AHMA trading at $1.85, typical drivers of single-day drops of this magnitude include delayed earnings misses or guidance cuts that may not have immediate coverage, short-seller activity or negative reports circulating off major newswires, sudden liquidity events or insider selling, or technical breakdown through key support levels triggering algorithmic selling. Without headline confirmation, the cause remains speculative. The stock's ranking as the 15th biggest loser suggests this was a material move affecting multiple traders, but without documented news, we cannot establish the specific triggering event versus inferring it retroactively from price action alone.

SLBT

Horizon Space Acquisition II Corp.Healthcare

$4.52−$1.27

-21.9%

NASDAQ · Mkt cap $1.8 B

SL Science (SLBT) fell 21.93% following a late Thursday announcement of a wider-than-expected 2025 net loss, signaling deteriorating financial performance year-over-year.

The headline indicates that SL Science reported 2025 net losses that expanded relative to the prior year, which is a clear negative catalyst for equity holders. The incomplete nature of the headline snippet prevents confirmation of exact loss figures, guidance commentary, or management explanations, but the directional message is unambiguous: losses deepened. For a SPAC-related or pre-revenue biotech/space company like Horizon Space Acquisition II, widening net losses typically trigger sharp selloffs because investors view mounting cash burn without corresponding revenue growth as unsustainable. The 21.93% single-day drop is proportionate to earnings disappointment in early-stage companies where margin of safety is already thin.

BTQ

BTQ Technologies Corp. Common StockTechnology

$4.44−$1.24

-21.8%

NASDAQ · Mkt cap $528 M

BTQ dropped 21.76% on no news headlines in the last 48 hours, suggesting the move was driven by technical selling, market sentiment, or an untracked announcement outside the RSS feed window.

No news headlines were found in the last 48 hours covering BTQ, which makes it difficult to pinpoint a specific catalyst for the sharp 21.76% decline. For a microcap technology stock like BTQ, such moves without visible news can stem from several sources: technical breakdown below a support level triggering algorithmic selling, sector-wide pressure in blockchain or quantum computing (depending on BTQ's business), insider transactions, short covering reversals, or delayed announcements not yet picked up by major news feeds. The stock's rank as the 17th biggest loser suggests broad market participation in the sell-off rather than isolated shareholder action, which leans toward either market-wide risk-off sentiment or a category-level event affecting similar companies.

FAMI

Farmmi, Inc.Consumer Defensive

$1.06−$0.29

-21.5%

NASDAQ · Mkt cap $3.9 M

No news headlines were found in the last 48 hours to explain FAMI's 21.48% decline, making the specific catalyst unknown without additional context.

The absence of recent news makes it impossible to identify a concrete trigger for Farmmi's sharp drop. FAMI is a small-cap agricultural processing company listed on NASDAQ, and stocks in this category are often sensitive to a mix of factors: delayed earnings announcements or disappointing quarterly results posted outside the news feed window, changes in commodity prices affecting input or output margins, shifts in customer concentration or contract terms, currency headwinds for export-focused operations, or broader sector rotation away from small-cap or agriculture-related equities. Without a headline, a reasonable hypothesis is that an earnings release, guidance revision, or material update occurred but was not yet captured in the RSS feed at the time of this snapshot, or the move may reflect technical selling or a delayed market reaction to older developments not resurfaced in recent coverage.

AVXX

Defiance Daily Target 2X Long AVAV ETF

$5.96−$1.61

-21.3%

NASDAQ

No news headlines were available in the last 48 hours, but AVXX is a 2X leveraged ETF tracking Defiance AVAV (aerospace and defense stocks), so the 21% decline likely reflects a sharp drop in the underlying AVAV index amplified by the 2X leverage.

AVXX is a daily rebalancing leveraged ETF that targets 2X exposure to the Defiance AVAV ETF. Without news headlines, the price action cannot be directly attributed to company-specific announcements. However, the structure of this security provides a clear explanation: leveraged ETFs amplify daily moves in their underlying index, so a roughly 10-11% decline in the AVAV index would produce approximately a 21% loss in AVXX on the same day. The aerospace and defense sector was likely hit by broader market weakness, sector rotation, geopolitical developments, or defense-related economic concerns. Examining AVAV's constituent holdings (major defense contractors) and daily market conditions on 2026-06-22 would be necessary to identify the root cause, but the magnitude of AVXX's move is consistent with leveraged amplification of an underlying sector decline.

GPUS

Hyperscale Data, Inc.Industrials

$0.29−$0.07

-20.3%

AMEX · Mkt cap $31 M

Hyperscale Data announced a $300 million at-the-market stock offering, triggering a 20% sell-off as investors reacted negatively to the dilution and capital raise announcement.

The headline directly links the 20% premarket decline to Hyperscale Data's announcement of a $300 million at-the-market (ATM) stock offering program. ATM offerings are commonly viewed negatively by existing shareholders because they represent near-term dilution and often signal that management believes the stock is overvalued relative to their need for capital, or that the company faces liquidity constraints. While the same headline mentions an "ambitious growth roadmap," the market's reaction suggests investors weighted the dilution risk more heavily than any growth prospects. The timing and magnitude of the decline align cleanly with the announcement, making this a straightforward equity issuance reaction rather than a fundamental business deterioration or technical event.

SOWG

Sow Good Inc.Consumer Defensive

$3.09−$0.78

-20.2%

NASDAQ · Mkt cap $68 M

No news headlines were found in the last 48 hours, so the 20% drop cannot be attributed to a publicly reported event. The decline likely reflects either a delayed market reaction to earlier news, technical selling, or an untracked announcement.

The absence of news in Yahoo Finance's RSS feed over the past two days makes it impossible to pinpoint a specific catalyst for SOWG's sharp 20% decline. This could mean the triggering event occurred more than 48 hours ago and the market is only now repricing, or it could reflect intraday trading dynamics unrelated to fundamental announcements. For a small-cap stock like SOWG (trading at $3.09), typical drivers of sharp single-day moves include earnings surprises, sector-wide selloffs, shifts in insider sentiment, or thin liquidity amplifying price swings. Without access to pre-market news, analyst downgrades, or real-time social sentiment data, we cannot distinguish between these scenarios. The rank as the 21st biggest loser suggests the move was market-wide notable, not isolated to SOWG alone, which could point to sector rotation or a broader market event, but confirmation requires additional data.

ATLN

Atlantic International Corp.Industrials

$0.44−$0.11

-20.1%

NASDAQ · Mkt cap $61 M

No news headlines were found in the last 48 hours, so the 20% decline cannot be attributed to a specific announced event. The move likely reflects either technical selling pressure, a delayed market reaction to prior news, or an untracked development specific to Atlantic International Corp.

The absence of recent headlines in the financial press makes it impossible to point to a concrete catalyst for the 20% single-day drop. For a micro-cap stock trading at $0.44, typical causes of sharp moves without visible news coverage include technical breakdown through support levels, margin liquidations, execution against a large seller, or delayed market reaction to company-specific developments that did not generate broad-based press coverage. Penny stocks and very low-priced securities are also more prone to liquidity events, rumor-driven trading, and announcement delays that may not immediately surface in mainstream financial news feeds. Without access to company filings, insider trades, or real-time chat activity, attribution remains speculative.

VVOS

Vivos Therapeutics, Inc.Healthcare

$0.40−$0.10

-19.6%

NASDAQ · Mkt cap $3.8 M

Vivos announced an extension of a debt-to-equity financing agreement with Streeterville on the same day the stock fell 19.56%, suggesting investor concerns about dilution or the implications of extended restructuring negotiations outweighed the company's reaffirmation of commitment to the convers…

On June 22, Vivos released a headline indicating it had extended the timeframe of a strategic financing agreement with Streeterville and reaffirmed commitment to convert debt into common stock and perpetual preferred equity. The timing of this announcement coinciding with a steep 19.56% intraday decline suggests the market interpreted the extension negatively. Possible interpretations include: the extension signals the original timeline was missed, raising questions about operational execution; the conversion structure dilutes existing shareholders; or the extended timeline raises uncertainty about the company's near-term financial stability. The separate healthcare sector update showing broader sector strength makes this move stock-specific rather than sector-driven. Without access to the full press release details, exact terms of the extension, or prior market expectations, the precise reason for the sell-off remains partially unclear, though debt restructuring announcements often trigger dilution concerns in small-cap biomedical stocks.

VELO

Velo3D, Inc.Technology

$24.31−$5.55

-18.6%

AMPGR

Amplitech Group, Inc. Series A Right

$3.25−$0.74

-18.5%

NASDAQ

No news headlines appeared in the last 48 hours, so the 18.55% drop cannot be attributed to a specific announced catalyst. The decline likely reflects market-wide selling, technical weakness, or off-exchange news not yet captured in major feeds.

The absence of any news headlines in the provided 48-hour window means this decline occurred without obvious public announcement or widely reported event. For a small-cap microcap security like Amplitech Series A Rights, this kind of move can stem from several sources: broader market selloff affecting illiquid names disproportionately, technical breakdown below key support levels, a delisting risk alert or regulatory filing not yet propagated to major news feeds, short-squeeze unwinding, or private information leaking ahead of formal disclosure. Series A rights structures themselves can be volatile due to low float and redemption mechanics. Without access to Level 2 quotes, insider trades, SEC filings filed in the last 24 hours, or OTC news networks, the specific trigger remains unknown but is likely either technical or driven by firm-specific news not yet indexed in Yahoo Finance's RSS.

BFLY

Butterfly Network, Inc.Healthcare

$7.27−$1.63

-18.3%

NYSE · Mkt cap $1.9 B

The headline announces a positive AI partnership with Midjourney and investor Michael Burry enthusiasm, yet the stock dropped 18.31%, suggesting the market either misinterpreted the news, reacted to undisclosed negative information, or the headline itself may be misleading or outdated relative to…

The provided headline is strongly positive on its face: a major co-development agreement with Midjourney for AI-powered imaging using Butterfly's ultrasound-on-chip technology, plus apparent approval from prominent investor Michael Burry. However, the stock fell sharply on the same day the headline was published. This disconnect suggests either the market received contradictory information not captured in the headline, the partnership details proved less valuable than initially perceived, or there was negative news released after the morning headline that dominated trading sentiment. Alternatively, the headline timestamp and actual market reaction timing may be misaligned. Without additional news context, it is difficult to definitively explain a -18% drop when the only visible headline is positive. Biotech and medtech stocks can be volatile on contract announcements if terms are deemed underwhelming or if broader market headwinds override company-specific news.

TRGSR

TRG Latin America Acquisitions Corp. Rights

$0.18−$0.04

-18.2%

NASDAQ

No news headlines were found in the last 48 hours, so the 18% drop on TRGSR is unexplained by published events; the most likely cause is a technical or market-driven shift in a low-liquidity special-purpose acquisition right, which can be highly volatile without news.

TRGSR is a rights instrument tied to TRG Latin America Acquisitions Corp., a special purpose acquisition company (SPAC). Rights offerings are inherently speculative and thinly traded; they often experience sharp price swings driven by sentiment about the underlying SPAC's merger prospects, de-SPAC timelines, or redemption announcements rather than daily news flow. The absence of headlines in the last 48 hours does not rule out (a) a prior announcement now being priced in, (b) redemption pressure ahead of a shareholder vote, (c) weakness in the broader SPAC market, or (d) a shift in trader sentiment on Latin American acquisition targets. Without visibility into SPAC-specific filings or broader indices, attribution remains speculative but rooted in the security's structural characteristics.

ASTC

Astrotech CorporationTechnology

$11.27−$2.38

-17.4%

NASDAQ · Mkt cap $16 M

No news headlines were reported in the last 48 hours, so the 17.44% drop cannot be tied to a specific announced event. The decline likely reflects either a delayed market reaction to earlier news, technical selling, or unannounced company-specific developments.

The absence of recent headlines makes it impossible to pinpoint a direct cause for ASTC's sharp 17.44% decline. Astrotech Corporation is a small-cap aerospace and technology company, and stocks in this category can be volatile and sensitive to earnings misses, contract losses, cash burn concerns, insider selling, or shifts in defense or space-related funding. Without access to intraday news, earnings releases, SEC filings, or analyst downgrades that may have occurred outside the Yahoo Finance RSS feed, we cannot rule out any of these factors. The stock's rank as the 28th biggest loser suggests the move is real and material, but its cause remains opaque from the information provided.

AKAN

Akanda Corp.Healthcare

$15.07−$3.13

-17.2%

NASDAQ · Mkt cap $2.6 M

No news headlines are available in the last 48 hours to explain the 17.20% single-day drop. The decline likely stems from sector-wide weakness, technical selling, or an untracked event such as a clinical setback, regulatory concern, or analyst downgrade in the cannabis or specialty pharma space.

Akanda Corp operates in the cannabis and specialty pharmaceutical sector, which can be volatile and sensitive to regulatory developments, clinical trial results, competitive pressures, and broader cannabis industry sentiment. With no news coverage appearing in Yahoo Finance RSS feeds over the past 48 hours, the trigger for a 17 percent intraday loss remains unidentified from publicly visible sources. Possible explanations include a negative development announced through a press release or conference call that has not yet been picked up by major news aggregators, a shift in investor sentiment tied to sector dynamics or macro factors, or technical selling pressure that may have accumulated over time. Without access to the company's official statements or real-time trading data showing the exact timing of the move, attribution remains speculative.

PCLA

PicoCELA Inc.Communication Services

$4.00−$0.81

-16.8%

NASDAQ · Mkt cap $62 M

No headlines were found in the last 48 hours for PCLA, so the 16.84% drop cannot be attributed to a publicly reported news event. The decline likely reflects broader market sentiment, technical selling, or private company-specific developments not yet captured in major news feeds.

PCLA dropped sharply on June 22 without any identifiable news catalyst in the recent headlines provided. This absence of news does not mean there was no catalyst—it may simply mean the trigger has not yet been widely reported, was released through non-traditional channels, or occurred just outside the capture window. For a microcap biotech or specialty stock like PicoCELA, typical catalysts for sharp single-day declines include: (1) clinical trial setbacks or regulatory feedback communicated through press release or SEC filing rather than major news aggregators, (2) insider selling or shareholder dilution announcements, (3) loss of a key partnership or contract, or (4) shifts in analyst sentiment. Without access to the company's own disclosures or real-time trading data, the precise cause remains speculative.

RVNL

GraniteShares 2x Long RIVN Daily ETF

$25.60−$5.17

-16.8%

NASDAQ

No news headlines were found in the last 48 hours, but RVNL is a 2x leveraged daily reset ETF tracking Rivian stock, so a sharp decline in Rivian shares would be mechanically amplified approximately twofold in this fund.

The absence of any news in the last 48 hours means we cannot identify a specific catalyst from headlines. However, RVNL is a leveraged ETF with 2x daily reset mechanics, meaning it is designed to amplify moves in its underlying asset—Rivian Automotive (RIVN)—by a factor of two on a daily basis. A -16.80% drop in RVNL is consistent with a roughly -8% to -9% move in RIVN stock itself, amplified by the fund's structural leverage. The decline is most likely attributable to a significant adverse move in Rivian shares, though without access to RIVN's price action or news for that period, we cannot confirm the cause. Possibilities include earnings disappointment, production or delivery setbacks, competitive pressure in the EV market, or broader sector rotation away from EV stocks, but these remain hypotheses rather than established facts.

CGTL

Creative Global Technology Holdings Limited Ordinary SharesConsumer Cyclical

$0.34−$0.07

-16.7%

NASDAQ · Mkt cap $8.2 M

No news headlines were found in the last 48 hours for CGTL, so the 16.73% decline likely stems from a company announcement, SEC filing, broader market sector weakness, or technical selling, but the specific catalyst cannot be identified from available information.

The absence of any Yahoo Finance headlines in the last 48 hours surrounding a 16.73% single-day drop is notable and suggests either that the trigger occurred outside the standard news cycle, came via direct SEC filing or company release rather than press distribution, or involved intraday rumors and technical factors. For a micro-cap stock trading at $0.34, common drivers of sharp declines without immediately visible headlines include reverse stock splits, dilutive equity issuances, insider selling, regulatory warnings, or liquidation pressure tied to options expiration or fund rebalancing. The stock's position as the 32nd largest loser today also suggests this may be part of a broader sector rotation or micro-cap selloff rather than an isolated company-specific event. Without access to SEC Edgar filings, company press releases, or social media sentiment from the snapshot date, the most honest assessment is that a material negative catalyst occurred but remains unconfirmed by the headline sources provided.

SPCX

Space Exploration Technologies Corp.Industrials

$154.60−$30.40

-16.4%

NASDAQ · Mkt cap $2.0 T

SpaceX shares fell 16.4% on news of its first-ever bond sale announcement, which spooked investors who had been treating the stock as a high-growth equity rather than a leveraged borrower, compounded by broader tech sector weakness.

The primary headline establishes that SpaceX announced its first investment-grade dollar bond offering on June 22, and multiple sources confirm the market reacted negatively to this news. The bond sale itself appears to have triggered the decline, with headlines explicitly stating "The Stock Market Doesn't Like It" and noting investors are "digesting" the debt issuance. This represents a shift in how the company funds growth, from purely equity-financed to using leverage. Secondary factors include broader tech sector rotation toward defensive stocks and blue chips as oil prices eased and geopolitical tensions with Iran cooled, causing investors to exit growth names like SpaceX. However, the bond sale announcement appears to be the primary catalyst for SPCX's specific 16% drop, marking its third consecutive day of losses.

GELS

Gelteq Limited Ordinary SharesHealthcare

$0.87−$0.17

-16.3%

NASDAQ · Mkt cap $6.0 M

No news headlines were reported in the last 48 hours for GELS, so the 16.28% drop cannot be directly attributed to a disclosed event. The decline likely stems from technical selling, broader market conditions, or undisclosed corporate developments.

The absence of any news headlines in the Yahoo Finance RSS feed over the past two days makes it impossible to connect the substantial 16.28% decline to a specific catalyst. For a micro-cap or lower-volume stock like GELS trading at $0.87, price moves of this magnitude can occur from several sources: thin liquidity amplifying modest selling pressure, technical chart breaks triggering stop-loss orders, sector-wide weakness affecting similar companies, or delayed disclosure of corporate events not yet picked up by major news feeds. It is also possible that news exists but has not yet been indexed by the RSS feed, or that the move reflects informed trading ahead of an announcement. Without supporting headlines or structural knowledge of the company, attributing causality is speculative.

CREG

Smart Powerr Corp.Utilities

$2.32−$0.45

-16.2%

NASDAQ · Mkt cap $499 K

No news headlines were found in the last 48 hours explaining Smart Powerr Corp.'s 16.25% drop, making the cause unclear. The decline may reflect technical selling, market sentiment toward microcap stocks, or untracked company developments.

Yahoo Finance RSS returned zero headlines for CREG in the past two days, so there is no news-based explanation available for this significant intraday loss. Smart Powerr Corp. trades on NASDAQ as a relatively low-priced stock, which typically makes it more sensitive to retail trading flows, short-covering reversals, and momentum-driven volatility. The stock's rank as the 35th biggest loser suggests it experienced notably worse performance than the broader market or a specific sector on June 22. Possible drivers in the absence of disclosed news could include: deterioration in a specific micro-cap or renewable-energy subsector, a delayed press release or filing not yet indexed by major news feeds, or technical liquidation. Without headline evidence or detailed float and insider-ownership data, attribution remains speculative and limited to categorical inference.

111, Inc.Healthcare

$3.70−$0.71

-16.1%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 16.1% drop cannot be directly attributed to a specific announcement or disclosure. The decline is likely due to general market sentiment, technical selling, or company-specific factors not yet reflected in public news feeds.

YI (111, Inc.) experienced a significant single-day loss of 16.1%, ranking among the day's biggest losers, yet no relevant news headlines appeared in the search results for the preceding 48 hours. This disconnect between a sharp price move and absent news coverage is common with lower-volume or lower-capitalization stocks. The decline could stem from several typical catalysts: delayed earnings disappointment now surfacing, unexpected insider selling or change in capital structure, sector rotation out of Chinese or technology names, options expiration effects, or negative commentary from analysts or social media. Without headline confirmation, it remains difficult to pinpoint the exact driver, though the magnitude of the drop suggests a material negative event rather than pure noise.

MODD

Modular Medical, Inc.Healthcare

$4.34−$0.81

-15.7%

NASDAQ · Mkt cap $13 M

No news headlines were available in the last 48 hours to explain MODD's 15.73% decline, so the cause remains unclear without additional information about market conditions or company-specific events.

The absence of recent headlines makes it impossible to identify a specific catalyst for this sharp single-day loss. MODD is a small-cap medical device company, and stocks in this category can be sensitive to several invisible-to-headline factors: institutional rebalancing, options expiration mechanics, sector rotation away from medical device stocks, execution of pre-announced insider share sales, or delayed news that hasn't yet surfaced in public feeds. It is also possible that negative news broke outside the 48-hour window captured here, or that a material announcement was made through an SEC filing (8-K, press release) that the news aggregator did not yet index. Without either confirmatory headlines or structural knowledge of MODD's specific circumstances (convertible debt maturity, clinical trial outcomes expected, analyst downgrades), the root cause cannot be determined from available evidence.

NAMI

Jinxin Technology Holding Company American Depositary SharesCommunication Services

$0.21−$0.04

-15.7%

NASDAQ · Mkt cap $9.0 M

No news headlines were found in the last 48 hours to explain NAMI's 15.71% decline, so the cause remains unknown and could reflect a delayed announcement, technical selling, or broader market conditions.

The absence of any recent news in the 48-hour window before this snapshot makes it impossible to pinpoint a specific catalyst for NAMI's sharp drop. Stocks in the micro-cap and penny-stock range, which NAMI appears to occupy at $0.21 per share, are often sensitive to liquidity events, short-seller activity, warrant or rights expirations, earnings surprises, regulatory filings, or delayed disclosures that may not immediately surface in major news feeds. Without substantive information about NAMI's business fundamentals, insider transactions, or recent corporate actions, only generic hypotheses are available: either (a) an announcement or filing was made that hasn't yet propagated to public financial news aggregators, or (b) technical weakness or sentiment-driven selling in a thinly traded security amplified a minor trigger into a large percentage move.

OPTH

Optimi Health Corp.Healthcare

$4.24−$0.79

-15.6%

HUBC

HUB Cyber Security Ltd.Technology

$1.68−$0.31

-15.6%

NASDAQ · Mkt cap $23 M

HUBC dropped 15.58% on June 22, but no news headlines were reported in the prior 48 hours, so the trigger cannot be identified from available public disclosures.

The absence of any news in the last 48 hours makes it difficult to pinpoint the cause of this sharp 15.58% decline. For a cybersecurity stock like HUBC, typical catalysts for such moves include earnings misses or guidance reductions, loss of a major customer or contract, adverse regulatory developments, insider selling, or broader sector rotation out of smaller-cap cyber names. The stock's low absolute price of $1.68 suggests it may be microcap or in financial distress, making it susceptible to technical selling, short covering reversal, or rumored bad news not yet published to major news feeds. Without any substantive headline, the cause remains speculative—it could be an announcement made on the company website or a call that markets reacted to before formal press distribution, or simply technical selling pressure in a weak period for the sector.

ENRD

Einride AB American Depositary SharesTechnology

$7.11−$1.31

-15.5%

NASDAQ · Mkt cap $863 M

No news headlines were found in the last 48 hours to explain Einride's 15.54% decline, so the move likely stems from broader market weakness, sector rotation, or undisclosed company developments not yet reflected in major news feeds.

The absence of any reported headlines in the last 48 hours makes it impossible to pinpoint a specific catalyst for the sharp 15.54% drop. Einride is an electric vehicle logistics company with a relatively small public float, and such stocks can be sensitive to shifts in EV sentiment, changes in funding outlooks, or operational concerns. Without named news events, the decline could reflect sector-wide headwinds affecting EV and logistics companies, a delayed earnings miss or guidance cut that hasn't yet surfaced in major financial media, insider activity, or technical selling. It is also possible that company-specific developments were announced through channels not yet captured by Yahoo Finance RSS feeds at the time of this snapshot.

MNTS

Momentus Inc.Industrials

$8.76−$1.59

-15.4%

NASDAQ · Mkt cap $80 M

No news headlines were found in the last 48 hours, so the 15.36% decline cannot be directly attributed to a specific announced event. The drop may reflect market sentiment, technical selling, or a delayed reaction to earlier developments.

The absence of recent headlines makes it difficult to pinpoint a precise cause for MNTS's sharp 15.36% drop on June 22, 2026. Momentus is a space-tech company focused on orbital logistics and satellite servicing, sectors sensitive to regulatory changes, funding announcements, contract wins or losses, and broader risk-sentiment shifts. Stocks in this category can move sharply on execution updates, space policy developments, or changes in investor appetite for high-risk growth equities. Without corroborating news in the last 48 hours, the decline could reflect a delayed market reaction to an earlier announcement, profit-taking after a prior run, technical breakdown below a key support level, or a market-wide rotation out of small-cap space stocks. Sector-wide or macro headwinds are also possible but cannot be confirmed from the data provided.

GRAN

Grande Group Limited Class A Ordinary SharesFinancial Services

$1.34−$0.24

-15.2%

NASDAQ · Mkt cap $31 M

No news headlines were found in the last 48 hours, so the 15.19% decline cannot be attributed to a specific announced catalyst. The drop likely reflects either delayed market reaction to unreported news, technical selling pressure, or broader sector weakness.

The absence of recent headlines in the Yahoo Finance RSS feed is notable given the magnitude of the decline. For a stock ranked number 43 among daily losers, there would typically be an identifiable catalyst such as earnings disappointment, guidance reduction, insider selling, analyst downgrade, or operational setback. Since no such headlines appear within the 48-hour window, the move could reflect several possibilities: a news event that has not yet been widely distributed through standard financial news feeds, a technical breakdown that triggered automatic selling or margin calls, short covering activity, or a delayed market reaction to information released more than 48 hours ago. Without access to real-time trading data, order flow, or social media sentiment, it is impossible to determine which mechanism drove the decline. The stock's relatively low price of 1.34 dollars may also indicate a microcap or distressed issuer prone to volatility regardless of news.

SGC

Superior Group of Companies, Inc.Consumer Cyclical

$11.63−$2.08

-15.2%

NASDAQ · Mkt cap $204 M

No news headlines were found in the last 48 hours, so the 15.17% drop cannot be directly attributed to a specific announced event; the decline likely stems from technical selling, sector weakness, or an untracked announcement.

Superior Group of Companies is a distributor of uniforms, workwear, and other branded products. The absence of headlines in the last 48 hours means we cannot point to earnings, guidance, contract wins or losses, or other company-specific announcements as the driver of this sharp decline. For a stock of this profile, typical catalysts that could trigger a 15% single-day drop without immediate media coverage include technical breakdown of support levels, broad market or sector rotation, short covering in reverse, or a significant news item that may not yet have been indexed by Yahoo Finance RSS. Without access to after-hours filings, press releases issued directly by the company, or trading data showing unusual volume or options activity, we cannot narrow the cause further than these broad categories.

CCTG

CCSC Technology International Holdings Limited Ordinary SharesIndustrials

$0.80−$0.14

-15.0%

NASDAQ · Mkt cap $8.8 M

No news headlines were available in the last 48 hours to explain CCTG's 15% decline, so the cause remains unclear without additional reporting or company disclosure.

The absence of any recent news headlines makes it impossible to pinpoint a specific catalyst for the 15% drop. CCSC Technology International is a smaller-cap NASDAQ-listed security, and stocks in this category can be sensitive to several categories of events even when not immediately reported: delayed earnings releases or warnings, insider selling, sector-wide weakness in technology or Chinese equities, technical liquidations, regulatory concerns, or simply illiquidity amplifying modest selling pressure. Without access to real-time trading data, social media sentiment, or company filings from the past 48 hours, it is not possible to determine whether the move was driven by company-specific news, market-wide technicals, or broader thematic pressure affecting similarly sized or Chinese tech stocks. The rank as the 45th biggest loser suggests meaningful volume was involved, but volume alone does not reveal intent.

ANGH

Anghami Inc.Communication Services

$4.84−$0.85

-14.9%

NASDAQ · Mkt cap $31 M

No news headlines were available in the last 48 hours, so the 14.94% decline cannot be directly attributed to a specific announcement or event; the drop likely stems from broader market conditions, technical selling, or unannounced company developments.

The absence of any recent news headlines makes it difficult to pinpoint a definitive cause for Anghami's sharp 14.94% decline on June 22, 2026. Anghami is a Middle Eastern music streaming platform, so typical catalysts for this stock would include quarterly earnings misses, user growth slowdowns, subscription revenue declines, licensing disputes, or regional geopolitical disruptions affecting its core markets. Without headlines, the move could reflect delayed negative news that hasn't yet appeared on Yahoo Finance's feed, technical selling pressure accumulating over days, analyst downgrades issued without earnings context, or sector-wide weakness in digital media companies. It is also possible that news broke after market hours or on platforms outside the RSS feed being monitored.

NEOV

NeoVolta Inc.Industrials

$2.37−$0.41

-14.7%

NASDAQ · Mkt cap $214 M

NeoVolta announced positive regulatory compliance and on-track manufacturing progress, yet fell 14.75%, suggesting the market either expected stronger news or is reacting to factors unrelated to this release.

The headline from June 22 reports that NeoVolta has confirmed FEOC compliance at its Georgia facility, received a legal opinion from a recognized law firm, and reaffirmed that commissioning and production ramp remain on schedule for Q3 2026. These are essentially confirmations of prior guidance rather than material new developments. The stock's sharp 14.75% decline on the same day the positive update was released is counterintuitive. Possible explanations include: first, the market may have priced in this compliance milestone already and interpreted the announcement as lacking incremental catalysts; second, there may be unrelated negative sentiment toward the small-cap battery or energy storage sector that day; third, there could be broader market weakness or negative news outside the provided headlines that outweighed the regulatory confirmation; or fourth, institutional or short-seller activity unrelated to fundamentals could be driving the move. Without additional context on broader market conditions or undisclosed news, the true driver remains unclear.

FISN

Deep Fission, Inc. Common StockIndustrials

$12.42−$2.14

-14.7%

NASDAQ · Mkt cap $461 M

Deep Fission announced the closing of a public stock offering on June 22, which likely triggered the 14.7% drop due to shareholder dilution from newly issued shares entering the market.

The company announced completion of a public offering of common stock on the same day as the sharp decline. Public offerings typically dilute existing shareholders' ownership percentage and can pressure the stock price immediately after closing, especially if the offering was large relative to the company's market capitalization or if investors worry about the timing and terms. The headline does not specify the size of the offering, pricing, or use of proceeds, which limits our ability to quantify the dilution impact. However, the temporal alignment between the offering announcement and the 14.7% drop is direct and logical. Without additional financial details or competing news, the offering closure is the most straightforward explanation for the magnitude of the move.

ARMG

Leverage Shares 2x Long ARM Daily ETF

$53.45−$9.04

-14.5%

NASDAQ

No news headlines are available for the last 48 hours, but ARMG is a 2x leveraged long ETF on ARM Holdings, so a sharp decline most likely reflects a significant drop in the underlying ARM stock price, amplified by the leverage factor.

The absence of any news headlines in the provided data makes it impossible to identify a specific catalyst for today's move. However, ARMG's structure as a 2x daily leveraged long ETF on ARM Holdings (the semiconductor design company) means its price movements are mechanically amplified versions of ARM's underlying performance. A 14.47% decline in ARMG would be consistent with approximately a 7.2% drop in ARM stock itself, accounting for leverage. Without access to ARM's own news or market conditions from June 22, 2026, the actual cause could be broad semiconductor sector weakness, company-specific negative developments affecting ARM, general market volatility, or technical factors. The leveraged structure can also amplify intraday volatility and mean reversion effects that may not correlate directly to fundamental news.

RCAX

Daily Target 2X Long RCAT ETF

$6.25−$1.05

-14.4%

NASDAQ

No news headlines were found in the past 48 hours, but RCAX is a 2X leveraged long ETF tracking RCAT, so a sharp drop likely reflects an underlying decline in RCAT shares amplified by the fund's leverage structure.

The absence of any news headlines in the provided RSS feed makes it impossible to identify a specific catalyst for today's 14.38% loss. However, RCAX's structure as a daily target 2X long leveraged ETF is material context. This fund amplifies daily price movements of its underlying RCAT holdings by a factor of two, meaning if RCAT itself declined roughly 7% today, RCAX would experience approximately that loss doubled. The move could stem from sector weakness, selling pressure in the underlying RCAT security, broad market volatility, or accumulated fund decay from daily rebalancing over time. Without news on RCAT or its holdings, or access to intraday market data, identifying the specific trigger remains speculative. Leveraged ETFs can also experience price gaps unrelated to their underlying when trading spreads widen or during high-volatility sessions.